92
Participants
Start Date
July 15, 2025
Primary Completion Date
January 15, 2026
Study Completion Date
January 30, 2026
Dexmedetomidine group (D group)
patients will receive intravenous dexmedetomidine (0.25 μg/kg diluted with normal saline to a volume of 5 ml solution) 10 min before the end of the surgical procedure.
Ketamine group (K group)
patients will receive intravenous ketamine (0.25mg/kg diluted with normal saline to a volume of 5 ml solution) 10 min before the end of the surgical procedure.
Midazolam group (M group)
patients will receive intravenous midazolam (0.05 mg/kg diluted with normal saline to a volume of 5 ml solution) 10 min before the end of the surgical procedure.
5ml of normal saline
patients will receive 5ml of normal saline intravenous10 min before the end of the surgical procedure as placebo.
Zagazig University
OTHER_GOV